FDA
-
-
-
-
-
-
-
Protalix BioTherapeutics to Announce First Quarter 2025 Financial and Business Results on May 9, 2025
-
-
-
-
-
-
-
Protalix BioTherapeutics to Announce Third Quarter 2024 Financial and Business Results on November 14, 2024
-
-
-
-
-
-
-
Protalix BioTherapeutics Reports First Quarter 2024 Financial and Business Results
-
-
-
-
-
-
-
Protalix BioTherapeutics to Announce Third Quarter 2023 Financial and Business Results on November 6, 2023
-
-
-
-
-
-
-
Protalix BioTherapeutics to Announce First Quarter 2023 Financial and Business Results on May 4, 2023
-
-
-
-
-
-
-
Protalix BioTherapeutics (PLX), Chiesi Announce FDA Acceptes Pegunigalsidase Alfa BLA
-
-
-
-
-
-
-
Protalix BioTherapeutics Announces Poster Presentations at the 2022 Program: 7th Update on Fabry Disease
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

